• Live Feeds
    • Press Releases
    • Insider Trading
    • FDA Approvals
    • Analyst Ratings
    • Insider Trading
    • SEC filings
    • Market insights
  • Analyst Ratings
  • Alerts
  • Subscriptions
  • AI SuperconnectorNEW
  • Settings
  • RSS Feeds
Quantisnow Logo
  • Live Feeds
    • Press Releases
    • Insider Trading
    • FDA Approvals
    • Analyst Ratings
    • Insider Trading
    • SEC filings
    • Market insights
  • Analyst Ratings
  • Alerts
  • Subscriptions
  • AI SuperconnectorNEW
  • Settings
  • RSS Feeds
PublishGo to AppAI Superconnector
    Quantisnow Logo

    © 2025 quantisnow.com
    Democratizing insights since 2022

    Services
    Live news feedsRSS FeedsAlertsPublish with Us
    Company
    AboutQuantisnow PlusContactJobsAI superconnector for talent & startupsNEW
    Legal
    Terms of usePrivacy policyCookie policy

    Southlake Health transforms diagnostic imaging with Philips AI-enabled MRI increasing capacity to address patient demand

    9/17/25 9:00:00 AM ET
    $PHG
    Medical Electronics
    Health Care
    Get the next $PHG alert in real time by email

    Innovative technology enhances patient comfort, expands therapeutic programs and opens capabilities in prostate, rectal, breast and cardiac health treatments

    Royal Philips (NYSE:PHG, AEX: PHIA)), a global leader in health technology and Southlake Health, today announced that the healthcare provider has selected Philips Ambition X MR with BlueSeal technology, the first high-performance and eco-friendly helium-free 1.5T scanner, to advance its diagnostic imaging capabilities with improved workflow efficiency and expanded imaging programs [1]. By implementing this leading-edge technology, Southlake Health has decreased scan times and improved patient throughput for some exams, benefiting the communities Southlake serves and the hospital's dedicated healthcare professionals. For over 20 years, Southlake has relied on Philips imaging technology and services to maintain its MRI's peak performance.

    This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20250917605278/en/

    Philips Ambition X MR with BlueSeal Technology at Southlake Health

    Philips Ambition X MR with BlueSeal Technology at Southlake Health

    "Southlake serves some of the fastest growing and aging communities in Canada, and we are excited to introduce to them the new Philips Ambition X MR, which provides a more comfortable experience for patients, while also reducing scan times and improving image quality," said Lisa Thain, MD, Staff Radiologist and Clinical Director of MRI at Southlake Health. "With this leading-edge technology, our teams will be able to provide faster, more confident diagnoses for patients – a win for everyone!"

    Philips' Ambition X MR with BlueSeal technology delivers superb image quality and performs MRI exams up to 3 times faster with Philips Compressed SENSE and SmartSpeed acceleration technologies [2]. Additional features such as MR Smart Workflow allow technologists to focus more on the patient while achieving high productivity with AI embedded in every step to simplify the path from image acquisition to diagnosis. Currently, Philips is the only helium-free scanner provider available in Canada with a 70 cm bore, eliminating the operational costs and downtime associated with traditional MRs [1]. A wider bore has resulted in patients reporting more comfortable exams and reduced feelings of claustrophobia.

    As the population continues to grow and age, it is anticipated that the need for diagnostic imaging will increase beyond the over 20,700 MRI scans Southlake completed last year. The Ambition's capabilities will help Southlake expand its imaging program to address growing demand for precise diagnostics and augment its cardiac care services by improving scheduling flexibility and efficiency. The Philips Ambition X MR with BlueSeal technology at Southlake is one of approximately 2,000 BlueSeal installations worldwide that collectively have saved 5 million liters of helium to date – a non-renewable and critical resource [1].

    "Southlake Health's desire to embrace the latest medical advancements available underscores its century-long commitment to delivering unmatched care," said Darran Fischer, Managing Director, Philips Canada. "This collaboration reflects our shared dedication to keeping patients at the centre of everything we do. Together, we aim to push the boundaries of diagnostic imaging, bringing improved access to care to the communities of Northern York Region and Southern Simcoe County."

    The implementation of this leading edge diagnostic technology at Southlake Health was made possible through the philanthropic investments and the unwavering commitment of organizations and community donors through the Southlake Health Foundation's HERE is Where Cancer Meets its Match campaign.

    [1] Helium-free operations. 7 liters of helium is permanently enclosed in the cryogenic circuit.

    Helium-free MRI BlueSeal technology - Philips

    [2] Compared to Philips SENSE imaging

    About Royal Philips

    Royal Philips (NYSE:PHG, AEX: PHIA)) is a leading health technology company focused on improving people's health and well-being through meaningful innovation. Philips' patient- and people-centric innovation leverages advanced technology and deep clinical and consumer insights to deliver personal health solutions for consumers and professional health solutions for healthcare providers and their patients in the hospital and the home.

    Headquartered in the Netherlands, the company is a leader in diagnostic imaging, ultrasound, image-guided therapy, monitoring and enterprise informatics, as well as in personal health. Philips generated 2024 sales of EUR 18 billion and employs approximately 67,300 employees with sales and services in more than 100 countries. News about Philips can be found at www.philips.com/newscenter.

    About Southlake Health

    For 100 years and counting, Southlake Health has built healthy communities through leading edge care with an unwavering pride for people, place, and performance. Over the years, Southlake Health has evolved into one of Canada's top healthcare organizations. It is more than a single centre. Southlake Health is a network of expertise, compassion, and excellence that delivers health and wellness, close to home.

    With 6,000 staff, medical staff, volunteers and learners, as well as an operating budget in excess of $600 million, Southlake Health operates several sites to deliver care to patients across northern York Region and southern Simcoe County. It also provides specialized cardiac and cancer care to patients as far north as Muskoka and as far south as North York through its regional programs.

    Southlake Health is committed to growing alongside the communities it serves. State-of-the-art technologies, advanced research, and the latest techniques help patients in every stage of life. In a recognition of its commitment to quality and patient safety, Southlake Health has received the highest distinction of Exemplary Standing from Accreditation Canada for the past 16 years. Known as a pioneer in innovative integrated care initiatives, the Southlake@home program has spread across Ontario to ensure care is always within reach.

    With support from its communities, Southlake Health will continue to save lives, push boundaries, and bring care closer to home for people today and for generations to come. Help us do more by donating at southlake.ca/foundation.

    *The opinions and clinical experiences presented herein are specific to the featured topic(s) and are not linked to any specific patient and are for information purposes only. The medical experience(s) derived from specified topic(s) may not be predictive of all patients. Individual results may vary depending on a variety of patient-specific attributes and related factors. Nothing in this news announcement is intended to provide specific medical advice or to take the place of written law or regulations.

    View source version on businesswire.com: https://www.businesswire.com/news/home/20250917605278/en/

    Avi Dines

    Philips North America

    Tel: +1-781-690-3814

    Email: [email protected]

    Anna Hogrebe

    Philips Global External Relations

    Tel.: +1 416 270 6757

    E-mail: [email protected]

    Get the next $PHG alert in real time by email

    Crush Q3 2025 with the Best AI Superconnector

    Stay ahead of the competition with Standout.work - your AI-powered talent-to-startup matching platform.

    AI-Powered Inbox
    Context-aware email replies
    Strategic Decision Support
    Get Started with Standout.work

    Recent Analyst Ratings for
    $PHG

    DatePrice TargetRatingAnalyst
    2/25/2025Neutral → Outperform
    Exane BNP Paribas
    2/20/2025Neutral → Buy
    UBS
    10/29/2024Underperform → Hold
    Jefferies
    5/13/2024Mkt Perform → Outperform
    Bernstein
    5/7/2024Underperform → Neutral
    Exane BNP Paribas
    4/30/2024Sell → Neutral
    UBS
    4/30/2024Underweight → Neutral
    JP Morgan
    2/7/2024Outperform → Underperform
    Exane BNP Paribas
    More analyst ratings

    $PHG
    Analyst Ratings

    Analyst ratings in real time. Analyst ratings have a very high impact on the underlying stock. See them live in this feed.

    View All

    Philips upgraded by Exane BNP Paribas

    Exane BNP Paribas upgraded Philips from Neutral to Outperform

    2/25/25 7:12:36 AM ET
    $PHG
    Medical Electronics
    Health Care

    Philips upgraded by UBS

    UBS upgraded Philips from Neutral to Buy

    2/20/25 7:05:01 AM ET
    $PHG
    Medical Electronics
    Health Care

    Philips upgraded by Jefferies

    Jefferies upgraded Philips from Underperform to Hold

    10/29/24 6:28:08 AM ET
    $PHG
    Medical Electronics
    Health Care

    $PHG
    Press Releases

    Fastest customizable press release news feed in the world

    View All

    Southlake Health transforms diagnostic imaging with Philips AI-enabled MRI increasing capacity to address patient demand

    Innovative technology enhances patient comfort, expands therapeutic programs and opens capabilities in prostate, rectal, breast and cardiac health treatments Royal Philips (NYSE:PHG, AEX: PHIA)), a global leader in health technology and Southlake Health, today announced that the healthcare provider has selected Philips Ambition X MR with BlueSeal technology, the first high-performance and eco-friendly helium-free 1.5T scanner, to advance its diagnostic imaging capabilities with improved workflow efficiency and expanded imaging programs [1]. By implementing this leading-edge technology, Southlake Health has decreased scan times and improved patient throughput for some exams, benefiting the

    9/17/25 9:00:00 AM ET
    $PHG
    Medical Electronics
    Health Care

    Philips intends to extend maturity of forward purchases of 4 million shares for long-term incentive plans

    September 15, 2025 Amsterdam, the Netherlands – Royal Philips (NYSE:PHG, AEX: PHIA)) announces today that it intends to extend the settlement of two forward contracts for 2 million long-term incentive plans shares each as part of the share repurchase program earlier announced on June 14, 2023. The planned extension will postpone the original maturity dates in Q4 2025 by one year to a new maturity date in Q4 2026. Further details will be available via this link. For further information, please contact:Michael FuchsPhilips Global External RelationsTel.: +31 6 1486 9261E-mail: [email protected] Dorin DanuPhilips Investor RelationsTel.: +31 20 59 77055E-mail: [email protected] A

    9/15/25 4:00:00 AM ET
    $PHG
    Medical Electronics
    Health Care

    Masimo Announces Expansion of Strategic Partnership with Philips

    Multi-Year Partnership Renewal with Broadened Focus Will Include Expedited Technology Adoption and Market-Based Strategic Development of Next-Generation Monitoring Solutions Masimo (NASDAQ:MASI) today announced a multi-year renewal and expansion of its strategic partnership with Royal Philips (NYSE:PHG, AEX: PHIA)). Building on over two decades of collaboration, this significant partnership expansion is designed to accelerate the integration of Masimo's monitoring technologies, such as industry-leading SET® pulse oximetry, into a variety of Philips multi-parameter patient monitors through 2026 and beyond. This includes integrating Masimo's Radius PPG® with Masimo-board equipped Philips

    9/11/25 8:00:00 AM ET
    $MASI
    $PHG
    Biotechnology: Electromedical & Electrotherapeutic Apparatus
    Health Care
    Medical Electronics

    $PHG
    SEC Filings

    View All

    SEC Form 6-K filed by Koninklijke Philips N.V. NY Registry Shares

    6-K - KONINKLIJKE PHILIPS NV (0000313216) (Filer)

    7/29/25 7:47:58 AM ET
    $PHG
    Medical Electronics
    Health Care

    SEC Form 6-K filed by Koninklijke Philips N.V. NY Registry Shares

    6-K - KONINKLIJKE PHILIPS NV (0000313216) (Filer)

    6/5/25 7:25:39 AM ET
    $PHG
    Medical Electronics
    Health Care

    SEC Form 6-K filed by Koninklijke Philips N.V. NY Registry Shares

    6-K - KONINKLIJKE PHILIPS NV (0000313216) (Filer)

    6/4/25 9:44:19 AM ET
    $PHG
    Medical Electronics
    Health Care

    $PHG
    Financials

    Live finance-specific insights

    View All

    Philips builds strong order intake momentum and drives margin expansion in Q2

    July 29, 2025 Q2 2025 Group Highlights Comparable order intake growth 6%Group sales EUR 4.3 billion, reflecting 1% increase in comparable salesIncome from operations EUR 400 millionAdjusted EBITA margin increased 130 bps to 12.4% of salesFree cash flow increased to EUR 230 millionPhilips increases full year 2025 outlook for Adjusted EBITA margin and free cash flow; reiterates comparable sales growth outlook Roy Jakobs, CEO of Royal Philips:"We are focused on driving profitable growth and delivering better care for more people. We built order intake growth momentum, supported by our recently launched AI-powered innovations. Our multi-year agreement with the Indonesian Ministry of Health re

    7/29/25 1:00:00 AM ET
    $PHG
    Medical Electronics
    Health Care

    Philips announces exchange ratio for 2024 dividend

    June 5, 2025 Amsterdam, the Netherlands – Royal Philips (NYSE:PHG, AEX: PHIA)), today announced that the exchange ratio for the dividend for the year 2024 is 1 new common share for every 23.6353 existing common shares. This ratio was based on the volume weighted average price on Euronext Amsterdam of May 30, June 2, and 3, 2025, of EUR 20.0600 and was calculated in a manner that the gross dividend in shares will be approximately equal to EUR 0.85. As a result, Philips will issue a total number of 22,980,748 new common shares. Shareholders have been given the opportunity to make their choice between a dividend in shares or (subject to certain conditions) in cash. The aggregate cash election

    6/5/25 4:00:00 AM ET
    $PHG
    Medical Electronics
    Health Care

    Philips delivers on Q1 results, with ongoing order intake growth

    May 6, 2025Q1 2025 Group performance Group sales EUR 4.1 billion, reflecting a 2% decline in comparable sales growth mainly due to China; slightly ahead of company outlook due to Personal Health growth and royalty phasingComparable order intake increased 2% despite China declineIncome from operations increased to EUR 154 millionAdjusted EBITA margin declined 80 bps to 8.6% of sales, driven by sales phasingFree cash outflow of EUR 1,091 million included EUR 1,025 million payment for Philips Respironics recall-related medical monitoring and personal injury settlements in USUpdated full year 2025 outlook for Adjusted EBITA margin and free cash flow; sales outlook remains unchanged Roy Jakobs,

    5/6/25 1:00:00 AM ET
    $PHG
    Medical Electronics
    Health Care

    $PHG
    Large Ownership Changes

    This live feed shows all institutional transactions in real time.

    View All

    $PHG
    Leadership Updates

    Live Leadership Updates

    View All

    Amendment: SEC Form SC 13D/A filed by Koninklijke Philips N.V. NY Registry Shares

    SC 13D/A - KONINKLIJKE PHILIPS NV (0000313216) (Subject)

    6/25/24 4:35:57 PM ET
    $PHG
    Medical Electronics
    Health Care

    SEC Form SC 13D/A filed by Koninklijke Philips N.V. NY Registry Shares (Amendment)

    SC 13D/A - KONINKLIJKE PHILIPS NV (0000313216) (Subject)

    5/16/24 5:52:57 PM ET
    $PHG
    Medical Electronics
    Health Care

    SEC Form SC 13D filed by Koninklijke Philips N.V. NY Registry Shares

    SC 13D - KONINKLIJKE PHILIPS NV (0000313216) (Subject)

    8/23/23 12:44:28 PM ET
    $PHG
    Medical Electronics
    Health Care

    New AI Rollouts Signal Shift From Hype to Healthcare Reality

    USA News Group News CommentaryIssued on behalf of Avant Technologies Inc. VANCOUVER, BC, June 24, 2025 /PRNewswire/ -- With populations again, and chronic diseases on the rise, global healthcare systems are facing enormous challenges ahead. However, there is hope on the horizon to alleviate some of these burdens, coming from the rise of AI in healthcare, as the new tech is proving it can improve diagnostic accuracies, drug discoveries, and administration work flow. Healthcare leaders are already reporting benefits, including reduced clinician workloads through voice-based AI tools and the use of AI agents to boost efficiency and support smarter care delivery. Behind the scenes, the tech is b

    6/24/25 9:45:00 AM ET
    $LLY
    $PHG
    $PLTR
    Biotechnology: Pharmaceutical Preparations
    Health Care
    Medical Electronics
    Computer Software: Prepackaged Software

    Philips shareholders approve all proposals at the AGM 2025

    May 8, 2025 Amsterdam, the Netherlands – Royal Philips (NYSE:PHG, AEX: PHIA)), today announced that its shareholders approved all proposals at the Annual General Meeting of Shareholders (AGM) 2025, including: The re-appointment of Ms Indra Nooyi and Ms Chua Sock Koong as members of the Supervisory Board.The appointment of Mr Bob White as a new member of the Supervisory Board.The re-appointment of Mr Marnix van Ginneken as member of the Board of Management. The discharge of the members of the Board of Management, and of the members of the Supervisory Board.A full overview of the resolutions taken at the AGM 2025 can be found below. Feike Sijbesma, Chairman of Philips' Supervisory Board, sa

    5/8/25 12:16:51 PM ET
    $PHG
    Medical Electronics
    Health Care

    Philips proposes new Supervisory Board appointments and reappointments, and Board of Management reappointment

    Mr David Pyott to retire from Philips' Supervisory Board after his third consecutive term.Mr Bob White proposed as new member of the Supervisory Board.Ms Indra Nooyi and Ms Chua Sock Koong proposed for reappointment as members of the Supervisory Board.Mr Marnix van Ginneken proposed for reappointment as member of Philips' Board of Management. February 19, 2025Amsterdam, the Netherlands – Royal Philips (NYSE:PHG, AEX: PHIA)), a global leader in health technology, today announced proposed Supervisory Board appointments and reappointments, and a proposed Board of Management reappointment. Mr David Pyott (British/American, 1953) will retire from Philips' Supervisory Board at the end of the Annu

    2/19/25 1:05:00 AM ET
    $PHG
    Medical Electronics
    Health Care